Clinical Trial Update: Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update showing adalimumab for induction and maintenance of remission in Crohn's disease; results were posted after completion of the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-09-02